A detailed history of Rational Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Rational Advisors LLC holds 1,543 shares of AMGN stock, worth $479,687. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,543
Holding current value
$479,687
% of portfolio
0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$268.87 - $324.56 $414,866 - $500,796
1,543 New
1,543 $438,000
Q3 2023

Nov 09, 2023

BUY
$218.65 - $271.46 $71,498 - $88,767
327 Added 42.41%
1,098 $295,000
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $656,094 - $775,818
-3,062 Reduced 79.89%
771 $171,000
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $840,164 - $1.02 Million
3,721 Added 3322.32%
3,833 $926,000
Q3 2022

Nov 08, 2022

BUY
$224.46 - $253.15 $224 - $253
1 Added 0.9%
112 $25,000
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $692 - $770
3 Added 2.78%
111 $27,000
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $23,681 - $26,197
108 New
108 $26,000
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $47,044 - $54,823
-212 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$216.38 - $257.67 $40,463 - $48,184
187 Added 748.0%
212 $49,000
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $626,046 - $696,214
-2,668 Reduced 99.07%
25 $6,000
Q2 2020

Aug 10, 2020

BUY
$197.81 - $242.74 $532,702 - $653,698
2,693 New
2,693 $635,000
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $113,717 - $150,820
-624 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $2.9 Million - $3.73 Million
-15,324 Reduced 96.09%
624 $150,000
Q3 2019

Nov 06, 2019

BUY
$174.11 - $208.62 $2.38 Million - $2.85 Million
13,659 Added 596.72%
15,948 $3.09 Million
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $318,897 - $373,819
-1,913 Reduced 45.53%
2,289 $422,000
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $304,585 - $343,333
-1,684 Reduced 28.61%
4,202 $799,000
Q4 2018

Feb 07, 2019

BUY
$178.4 - $208.25 $323,974 - $378,182
1,816 Added 44.62%
5,886 $1.15 Million
Q3 2018

Nov 08, 2018

BUY
$185.29 - $208.89 $322,960 - $364,095
1,743 Added 74.9%
4,070 $843,000
Q2 2018

Aug 07, 2018

SELL
$166.05 - $186.51 $117,895 - $132,422
-710 Reduced 23.38%
2,327 $429,000
Q1 2018

May 18, 2018

BUY
$169.43 - $198.0 $514,558 - $601,326
3,037 New
3,037 $518,000
Q4 2017

Feb 08, 2018

SELL
$168.79 - $188.59 $244,745 - $273,455
-1,450 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $242,570 - $276,950
1,450
1,450 $270,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rational Advisors LLC Portfolio

Follow Rational Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rational Advisors LLC with notifications on news.